The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

novabay.com

Founded Year

2000

Stage

Loan | IPO

Total Raised

$680K

Market Cap

0.01B

Stock Price

0.28

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals develops products for the eye care market. The company is focused on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States.

NovaBay Pharmaceuticals Headquarter Location

2000 Powell Street Suite 1150

Emeryville, California, 94608,

United States

510-899-8800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NovaBay Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NovaBay Pharmaceuticals is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

NovaBay Pharmaceuticals Patents

NovaBay Pharmaceuticals has filed 10 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/31/2014

4/18/2017

Contact lenses, Epidermal nevi, neoplasms, cysts, Disorders of sclera and cornea, Microbiology, Corrective lenses

Grant

Application Date

10/31/2014

Grant Date

4/18/2017

Title

Related Topics

Contact lenses, Epidermal nevi, neoplasms, cysts, Disorders of sclera and cornea, Microbiology, Corrective lenses

Status

Grant

Latest NovaBay Pharmaceuticals News

NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11

Aug 4, 2022

August 04, 2022 06:50 AM Eastern Daylight Time EMERYVILLE, Calif.--( BUSINESS WIRE )-- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time:     Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call: 866-777-2509 from within the U.S. 412-317-5413 from outside the U.S. The live webcast of the conference call also will be available at http://novabay.com/investors/events . A replay of the call will be available beginning two hours after its completion through September 1, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 9678917. The webcast will also be archived at http://novabay.com/investors/events . About NovaBay Pharmaceuticals, Inc: NovaBay Pharmaceuticals, Inc. creates science-based, problem-solving, accessible solutions for improved well-being through its two brands, Avenova® and DERMAdoctor®. Avenova products are scientifically created and clinically proven to help patients and consumers with common eye irritations. DERMAdoctor products are premium dermatologist-developed skincare solutions sold through traditional domestic retailers, digital beauty channels and international distributors. Socialize and Stay Informed on NovaBay’s Progress Like us on Facebook

NovaBay Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NovaBay Pharmaceuticals Rank

  • When was NovaBay Pharmaceuticals founded?

    NovaBay Pharmaceuticals was founded in 2000.

  • Where is NovaBay Pharmaceuticals's headquarters?

    NovaBay Pharmaceuticals's headquarters is located at 2000 Powell Street, Emeryville.

  • What is NovaBay Pharmaceuticals's latest funding round?

    NovaBay Pharmaceuticals's latest funding round is Loan.

  • How much did NovaBay Pharmaceuticals raise?

    NovaBay Pharmaceuticals raised a total of $680K.

  • Who are the investors of NovaBay Pharmaceuticals?

    Investors of NovaBay Pharmaceuticals include Paycheck Protection Program and Triton.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.